Xoma Ltd is a biotech royalty aggregator based in Union City, CA. With a portfolio of 70 assets and counting, the company acquires the economic rights to future milestone and royalty payments associated with partnered pre-commercial clinical candidates, providing non-dilutive, non-recourse funding to advance internal drug candidates.
Operating under a capital-efficient structure, Xoma actively acquires the rights to future potential milestone and royalty payments for pre-commercial therapeutic assets developed by pharmaceutical and biotech companies. Their portfolio approach mitigates single-asset binary exposure, aiming to deliver shareholder value.
Generated from the website